Drug Profile
Tebipenem pivoxil - Yunnan Institute of Materia Medica
Latest Information Update: 06 Sep 2023
Price :
$50
*
At a glance
- Originator Yunnan Institute of Materia Medica
- Class Anti-infectives; Anti-inflammatories; Antibacterials; Azabicyclo compounds; Azetidines; Carbapenems; Esters; Small molecules; Thiazoles
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 06 Sep 2023 Chemical structure information added
- 05 Sep 2023 Discontinued - Preclinical for Bacterial infections in China (PO)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Bacterial-infections in China (PO, Tablet)